| Carolyn C Constant, CRNA | |
|
4401 Wornall Rd, Kansas City, MO 64111 | |
| (816) 932-3679 | |
| Not Available |
| Full Name | Carolyn C Constant |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 17 Years |
| Location | 4401 Wornall Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114116753 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R1540417 (Minnesota) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 2018015166 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Saint Luke's South Hospital | Overland park, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
| Meritas Health Corporation | 6305748153 | 365 |
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
The Obama administration on Tuesday issued new guidance stating "the U.S. would not prosecute relief agencies for delivering aid to parts of Somalia controlled by the Islamist insurgent group al-Shabab, despite concerns that unrestricted aid in the failed state would be diverted to the wrong hands," Inter Press Service reports.
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.
As the United Nations, the European Commission, and the United States Food and Drug Administration evaluate the health and environmental risks associated with mercury, a known neurotoxin, carcinogen, mutagen, teratogen, and immune-system disruptor, new research continues to fuel concerns about Thimerosal, a mercury-based compound used as a preservative in inactivated flu vaccines.
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 in the treatment of metastatic colorectal cancer that is refractory to all standard therapy.
Application of a thrombin-soaked sponge after posterior cervical spine surgery allows patients to leave hospital earlier than normally expected, suggests research.
› Verified 2 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
The Obama administration on Tuesday issued new guidance stating "the U.S. would not prosecute relief agencies for delivering aid to parts of Somalia controlled by the Islamist insurgent group al-Shabab, despite concerns that unrestricted aid in the failed state would be diverted to the wrong hands," Inter Press Service reports.
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.
As the United Nations, the European Commission, and the United States Food and Drug Administration evaluate the health and environmental risks associated with mercury, a known neurotoxin, carcinogen, mutagen, teratogen, and immune-system disruptor, new research continues to fuel concerns about Thimerosal, a mercury-based compound used as a preservative in inactivated flu vaccines.
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 in the treatment of metastatic colorectal cancer that is refractory to all standard therapy.
Application of a thrombin-soaked sponge after posterior cervical spine surgery allows patients to leave hospital earlier than normally expected, suggests research.
› Verified 2 days ago
| Entity Name | Meritas Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801875091 PECOS PAC ID: 6305748153 Enrollment ID: O20040122001058 |
News Archive
The Obama administration on Tuesday issued new guidance stating "the U.S. would not prosecute relief agencies for delivering aid to parts of Somalia controlled by the Islamist insurgent group al-Shabab, despite concerns that unrestricted aid in the failed state would be diverted to the wrong hands," Inter Press Service reports.
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.
As the United Nations, the European Commission, and the United States Food and Drug Administration evaluate the health and environmental risks associated with mercury, a known neurotoxin, carcinogen, mutagen, teratogen, and immune-system disruptor, new research continues to fuel concerns about Thimerosal, a mercury-based compound used as a preservative in inactivated flu vaccines.
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 in the treatment of metastatic colorectal cancer that is refractory to all standard therapy.
Application of a thrombin-soaked sponge after posterior cervical spine surgery allows patients to leave hospital earlier than normally expected, suggests research.
› Verified 2 days ago
| Entity Name | Professional Anesthetic Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922053461 PECOS PAC ID: 2365425865 Enrollment ID: O20040607001480 |
News Archive
The Obama administration on Tuesday issued new guidance stating "the U.S. would not prosecute relief agencies for delivering aid to parts of Somalia controlled by the Islamist insurgent group al-Shabab, despite concerns that unrestricted aid in the failed state would be diverted to the wrong hands," Inter Press Service reports.
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.
As the United Nations, the European Commission, and the United States Food and Drug Administration evaluate the health and environmental risks associated with mercury, a known neurotoxin, carcinogen, mutagen, teratogen, and immune-system disruptor, new research continues to fuel concerns about Thimerosal, a mercury-based compound used as a preservative in inactivated flu vaccines.
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 in the treatment of metastatic colorectal cancer that is refractory to all standard therapy.
Application of a thrombin-soaked sponge after posterior cervical spine surgery allows patients to leave hospital earlier than normally expected, suggests research.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carolyn C Constant, CRNA 901 E 104th St, Mailstop 400s, Kansas City, MO 64131 Ph: (816) 502-7117 | Carolyn C Constant, CRNA 4401 Wornall Rd, Kansas City, MO 64111 Ph: (816) 932-3679 |
News Archive
The Obama administration on Tuesday issued new guidance stating "the U.S. would not prosecute relief agencies for delivering aid to parts of Somalia controlled by the Islamist insurgent group al-Shabab, despite concerns that unrestricted aid in the failed state would be diverted to the wrong hands," Inter Press Service reports.
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage caused by tumors, surgery, chemotherapy or radiation indicates gene therapy as a possible treatment.
As the United Nations, the European Commission, and the United States Food and Drug Administration evaluate the health and environmental risks associated with mercury, a known neurotoxin, carcinogen, mutagen, teratogen, and immune-system disruptor, new research continues to fuel concerns about Thimerosal, a mercury-based compound used as a preservative in inactivated flu vaccines.
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 in the treatment of metastatic colorectal cancer that is refractory to all standard therapy.
Application of a thrombin-soaked sponge after posterior cervical spine surgery allows patients to leave hospital earlier than normally expected, suggests research.
› Verified 2 days ago
Michael S Filla, RN, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2316 E Meyer Blvd, Kansas City, MO 64132 Phone: 816-276-4000 | |
Kelli A Pryor, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-1100 | |
Sydney L. Overton, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2316 E Meyer Blvd, Kansas City, MO 64132 Phone: 816-763-5446 Fax: 816-763-8426 | |
Adrienne Jill Rader, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2316 E Meyer Blvd, Kansas City, MO 64132 Phone: 816-763-5446 Fax: 816-763-8426 | |
Jon R Featherston, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-1100 | |
Daniel E Roberson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 Fax: 816-302-9939 | |
Dr. Vanessa Rae Jackson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 721 Ne 82nd Ter, Kansas City, MO 64118 Phone: 816-646-1242 |